Skip to content

Microbot Medical MBOT Other Commercial Liabilities

Other Commercial Liabilities at other companies

AngioDynamics logo
AngioDynamicsANGO
ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI
Stereotaxis logo
StereotaxisSTXS
TFX
TeleflexTFX
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's other commercial liabilities?
Microbot Medical (MBOT) reported other commercial liabilities of $1.98M in Q1 2026.
How has Microbot Medical's other commercial liabilities changed year-over-year?
Microbot Medical's other commercial liabilities increased by 22.3% year-over-year, from $1.62M to $1.98M.
What is the long-term trend for Microbot Medical's other commercial liabilities?
Over 5 years (2020 to 2025), Microbot Medical's other commercial liabilities has grown at a 24.2% compound annual growth rate (CAGR), from $883K to $2.61M.